companies / twosteptx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-02 json
| total_raised | 62,209,51062.2M | ○ |
|---|---|---|
| founded | null | |
| hq | San Carlos, California | |
| industry | unknown | |
| stage | null |
TwoStep Therapeutics is an oncology company working to expand the reach of targeted cancer therapies. It focuses on patients whose tumors are difficult to treat with existing precision approaches. The company aims to broaden which cancers and patient populations can benefit from targeted treatment rather than restricting it to a narrow set of indications.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-01-20 | Funding round | 62,209,51062.2M | null | ○ |
| fact | status | src |
|---|---|---|
| Funding round, $62.2M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $62.2M, 2026-01-20 → Funding round, $62.2M, 2026-01-20, ○ 2026-06-02 | latest_round | seed, $62.2M, 2026-01-20 → Funding round, $62.2M, 2026-01-20 | ○ 2026-06-02 |
Records begin 2026-09-24. all_changes